Thomas Ingenlath
Scope
Date
~
-
Bio & Pharma
Medytox establishes US subsidiary Luvantas
South Korean pharmaceutical company Medytox Inc. announced on Wednesday that its establishment of the US subsidiary Luvantas.The goal is the global ...
Jan 03, 2024 (Gmt+09:00)
-
Private equity
Affirma Capital’s Korean MD Thomas Shim promoted to partner
Global private equity firm Affirma Capital has promoted Seoul-based Managing Director Min Hyun (Thomas) Shim to partner, investment banking sources ...
Jun 20, 2023 (Gmt+09:00)
-
Pension funds
Thoma Bravo may attract $200 mn from NPS, KTCU
National Pension Service (NPS), Korean Teachers’ Credit Union (KTCU) and other institutional investors of South Korea are likely to contribute...
Feb 16, 2022 (Gmt+09:00)
-
M&As
Edison CEO aspires to be Korea’s Elon Musk with Ssangyong takeover
Kang Young-kwon, chairman and chief executive of South Korea’s Edison Motors Co., was virtually unheard of in the country’s automobile i...
Oct 22, 2021 (Gmt+09:00)
-
Pension funds
NPS adds APG, IFM Investors, Thoma Bravo as managers in Q4
The National Pension Service (NPS) has entrusted funds to three overseas alternative investment firms newly hired in the fourth quarter of last year...
Mar 01, 2021 (Gmt+09:00)
Latest News
- 1 NPS corp governance committee taps SNU professor as member
- 2 Korean banks broaden horizons to Mexico, Poland, Africa
- 3 Block deals of shares surge ahead of tighter regulation
- 4 Hyundai to develop hydrogen supercar for launch in 2026
- 5 Hyundai Motor unveils detailed $3.4 billion GBC new headquarters plan